Advantage of Co-Culture Strategy for Targeted Cancer Treatment and in Vitro Studies
| dc.contributor.author | Ulu, G. T. | |
| dc.contributor.author | Bayram, N. N. | |
| dc.contributor.author | Isoglu, S. Dincer | |
| dc.contributor.author | Baran, Y. | |
| dc.date.accessioned | 2025-09-25T10:40:09Z | |
| dc.date.available | 2025-09-25T10:40:09Z | |
| dc.date.issued | 2021 | |
| dc.description | Bayram, Nazende Nur/0000-0002-8697-1654; Baran, Yusuf/0000-0002-1056-4673; Ulu, Gizem Tugce/0000-0001-9265-9985; | en_US |
| dc.description.sponsorship | Scientific and Technological Research Council of Turkey [116R057] | en_US |
| dc.description.sponsorship | Research grants from the Scientific and Technological Research Council of Turkey, "Development of Breast Cancer Targeted, More Stable, IV Double-Moiety pHSensitive, Drug-Conjugated, Multifunctional Micelle-Based Nanocarriers and Investigation of Their in vitro Efficiency", Project Number: 116R057. | en_US |
| dc.identifier.doi | 10.1016/j.annonc.2021.08.309 | |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.issn | 1569-8041 | |
| dc.identifier.uri | https://doi.org/10.1016/j.annonc.2021.08.309 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12573/3205 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.ispartof | Annals of Oncology | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Advantage of Co-Culture Strategy for Targeted Cancer Treatment and in Vitro Studies | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | Bayram, Nazende Nur/0000-0002-8697-1654 | |
| gdc.author.id | Baran, Yusuf/0000-0002-1056-4673 | |
| gdc.author.id | Ulu, Gizem Tugce/0000-0001-9265-9985 | |
| gdc.author.wosid | Bayram, Nazende/Aag-3564-2021 | |
| gdc.author.wosid | Baran, Yusuf/F-8535-2012 | |
| gdc.author.wosid | Dinçer, Sevil/F-2160-2011 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::conference output | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | Abdullah Gül University | en_US |
| gdc.description.departmenttemp | [Ulu, G. T.; Baran, Y.] IYTE Izmir Inst Technol, Mol Biol & Genet Dept, Izmir, Turkey; [Bayram, N. N.; Isoglu, S. Dincer] Abdullah Gul Univ, Mat Sci & Nanotechnol Engn, Kayseri, Turkey | en_US |
| gdc.description.endpage | S370 | en_US |
| gdc.description.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.startpage | S370 | en_US |
| gdc.description.volume | 32 | en_US |
| gdc.description.woscitationindex | Science Citation Index Expanded - Conference Proceedings Citation Index - Science | |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.openalex | W3203208266 | |
| gdc.identifier.wos | WOS:000700527700032 | |
| gdc.index.type | WoS | |
| gdc.oaire.accesstype | BRONZE | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 0.0 | |
| gdc.oaire.influence | 2.4895952E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.popularity | 1.5483943E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.oaire.sciencefields | 0302 clinical medicine | |
| gdc.openalex.collaboration | National | |
| gdc.openalex.fwci | 0.0 | |
| gdc.openalex.normalizedpercentile | 0.16 | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.mendeley | 2 | |
| gdc.virtual.author | Dinçer İşoğlu, Sevil | |
| gdc.wos.citedcount | 0 | |
| relation.isAuthorOfPublication | dc7da285-b607-4186-9160-170212d09368 | |
| relation.isAuthorOfPublication.latestForDiscovery | dc7da285-b607-4186-9160-170212d09368 | |
| relation.isOrgUnitOfPublication | 665d3039-05f8-4a25-9a3c-b9550bffecef | |
| relation.isOrgUnitOfPublication | 4eea69bf-e8aa-4e3e-ab18-7587ac1d841b | |
| relation.isOrgUnitOfPublication | 5519c95e-5bcb-45e5-8ce1-a8b4bcf7c7b9 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 665d3039-05f8-4a25-9a3c-b9550bffecef |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Advantage of co-culture strategy for targeted cancer treatment and in vitro studies.pdf
- Size:
- 90.94 KB
- Format:
- Adobe Portable Document Format
- Description:
- Konferans Ögesi
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.44 KB
- Format:
- Item-specific license agreed upon to submission
- Description: